Stryker Corporation (SYK) To Go Ex-Dividend on June 30th

Stryker Corporation (NYSE:SYK) declared a quarterly dividend on Wednesday, May 6th. Investors of record on Tuesday, June 30th will be given a dividend of 0.88 per share by the medical technology company on Friday, July 31st. This represents a c) dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, June 30th.

Stryker has increased its dividend by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 32 consecutive years. Stryker has a dividend payout ratio of 23.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Stryker to earn $16.58 per share next year, which means the company should continue to be able to cover its $3.52 annual dividend with an expected future payout ratio of 21.2%.

Stryker Stock Up 5.1%

Shares of NYSE:SYK opened at $332.31 on Friday. The business’s 50 day simple moving average is $311.10 and its two-hundred day simple moving average is $339.93. The firm has a market cap of $127.39 billion, a P/E ratio of 38.46, a PEG ratio of 2.13 and a beta of 0.78. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. Stryker has a 52-week low of $281.00 and a 52-week high of $404.87.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the prior year, the firm earned $2.84 EPS. The company’s revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts forecast that Stryker will post 14.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have commented on SYK shares. Citigroup decreased their price target on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Canaccord Genuity Group reduced their price objective on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. Robert W. Baird set a $385.00 target price on shares of Stryker in a research report on Friday, May 1st. Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a report on Friday, May 1st. Finally, Needham & Company LLC dropped their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $395.33.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.